A multicenter randomized controlled trial of nevirapine versus a combination of zidovudine and lamivudine to reduce intrapartum and early postpartum mother-to-child transmission of human immunodeficiency virus type 1.
about
Prevention of vertical transmission of HIV-1 in resource-limited settingsOral non-steroidal anti-inflammatory drugs (single dose) for perineal pain in the early postpartum periodAntiretrovirals for reducing the risk of mother-to-child transmission of HIV infectionAntiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant womenAntiretrovirals for reducing the risk of mother-to-child transmission of HIV infectionOral non-steroidal anti-inflammatory drugs (single dose) for perineal pain in the early postpartum periodEfficacy of short-course AZT plus 3TC to reduce nevirapine resistance in the prevention of mother-to-child HIV transmission: a randomized clinical trialHIV-1 drug resistance emergence among breastfeeding infants born to HIV-infected mothers during a single-arm trial of triple-antiretroviral prophylaxis for prevention of mother-to-child transmission: a secondary analysisDevelopment of Nevirapine Resistance in Children Exposed to the Prevention of Mother-to-Child HIV-1 Transmission Programme in Maputo, MozambiqueChildren who acquire HIV infection perinatally are at higher risk of early death than those acquiring infection through breastmilk: a meta-analysisAnalysis of HIV early infant diagnosis data to estimate rates of perinatal HIV transmission in ZambiaFactors associated with coverage of cotrimoxazole prophylaxis in HIV-exposed children in South Africa.Systematic review of the efficacy of antiretroviral therapies for reducing the risk of mother-to-child transmission of HIV infection.Antiretroviral treatment and prevention of peripartum and postnatal HIV transmission in West Africa: evaluation of a two-tiered approach.A coarsened multinomial regression model for perinatal mother to child transmission of HIV.Rapid testing may not improve uptake of HIV testing and same day results in a rural South African community: a cohort study of 12,000 women.HIV: mother-to-child transmissionLow-cost HIV-1 diagnosis and quantification in dried blood spots by real time PCR.The contribution of family planning towards the prevention of vertical HIV transmission in Uganda.Incidence and risk factors of severe adverse events with nevirapine-based antiretroviral therapy in HIV-infected women. MTCT-Plus program, Abidjan, Côte d'Ivoire.Experiences in conducting multiple community-based HIV prevention trials among women in KwaZulu-Natal, South Africa.HIV: prevention of mother-to-child transmission.Antiretroviral drugs for preventing mother-to-child transmission of HIV in sub-Saharan Africa: balancing efficacy and infant toxicity.Toward elimination of perinatal HIV transmission: New Jersey hospital barriers to rapid HIV testing in labor and delivery, 2005.Efficacy and safety of an extended nevirapine regimen in infant children of breastfeeding mothers with HIV-1 infection for prevention of postnatal HIV-1 transmission (HPTN 046): a randomised, double-blind, placebo-controlled trial.Role of low-frequency HIV-1 variants in failure of nevirapine-containing antiviral therapy in women previously exposed to single-dose nevirapine.Prevention of perinatal HIV transmission: a review of novel strategies.What will it take to achieve virtual elimination of mother-to-child transmission of HIV? An assessment of current progress and future needsSafety and efficacy of HIV hyperimmune globulin for prevention of mother-to-child HIV transmission in HIV-1-infected pregnant women and their infants in Kampala, Uganda (HIVIGLOB/NVP STUDY).Sexually transmitted infections in pregnancy: prevalence, impact on pregnancy outcomes, and approach to treatment in developing countries.Pharmacologic and nonpharmacologic options for the management of HIV infection during pregnancy.Preventing postnatal transmission of HIV-1 through breast-feeding: modifying infant feeding practicesComparison of anti-retroviral therapy treatment strategies in prevention of mother-to-child transmission in a teaching hospital in EthiopiaPrevention of Parent to Child Transmission of HIV (PPTCT): An Effort of 4 Years in a Tertiary Centre.Anemia and Red Blood Cell Abnormalities in HIV-Infected and HIV-Exposed Breastfed Infants: A Secondary Analysis of the Kisumu Breastfeeding Study.Antiretroviral therapy and mother-to-child transmission of HIV-1.Epidemiology of Respiratory Disease in Malawi.Management of breech presentation in areas with high prevalence of HIV infection.German-Austrian recommendations for HIV1-therapy in pregnancy and in HIV1-exposed newborn, update 2008Developmental pharmacokinetic changes of Lamivudine in infants and children
P2860
Q22241479-376EA349-C446-467A-AF45-4B15ED069601Q24193261-18C2C815-114D-473F-BA4F-70343FEF8DACQ24235500-9C957319-7EEF-4509-B174-B9C0F0101EF4Q24236763-4A7BFADF-AF7D-4D6F-A2B3-1C164DE1EE77Q24243146-96C0B6D8-EAD6-4912-9120-0CEC7C5236B6Q26471110-636780AD-9F8D-4D7D-B379-2B60D1D25651Q28476329-FCE2F1E6-8556-49AB-A7C6-C016ADD03DF8Q28477542-10A47F62-110F-48DD-B2F4-C17EC019C950Q28546418-1D6C4164-0235-43E6-AD02-05D9C943A1D1Q28731813-1926D2D2-EA64-45C5-B688-FD332F761DACQ30558708-2F1F56F4-89DA-42EB-AA4F-F206FBE69731Q31116941-2D1E658F-4871-422B-A78E-DB5B9A866AE0Q33284135-140AAA33-7286-489C-A028-ACFA41DB1B29Q33294899-49B6AA35-A9A2-49D0-8B38-CF4EA17F4576Q33351797-A45C31F1-8013-4CF2-8E3E-51527B8A9B02Q33378905-B747389B-78B9-4D11-AD3D-F2DA4C0D405CQ33446714-1696D899-AA20-4507-8FE1-39553C6D99EAQ33463338-42D1A670-8047-4F15-8E39-A1DA36DF0E80Q33514838-F0C564AF-E341-4270-BDC9-A225DE3ADB41Q33615251-7ED2873D-B729-49E9-91A9-41E7C6E87855Q33848578-97973544-C70F-4E32-8E5F-D811C3108612Q33866493-543F5F2D-DCF2-4D87-AE2F-248463C2892EQ33897042-917DC31B-4C9D-4E5D-9B9A-0888307ECE1CQ34405657-1D7D0D4F-99D1-44BF-951B-FA5132BDA0B7Q34634644-9B2A70A0-E25A-42BE-87E8-2FA03C6B8B0DQ35021860-D5A8AB9A-5F67-42DD-803D-B2CC53D18584Q35207628-EA96F8F3-432B-449A-9A2D-AF60A6F3E97BQ35215012-EB56A6E3-E142-4FA0-ADA2-6C6F07DF9FBDQ35475930-46D580A6-9C54-44FB-9199-0CA63D488416Q35531854-5EB574E0-54C3-46A9-8D08-543CD10E26A2Q35557216-55857B08-A10D-4CB0-81DE-795D797D7882Q35628422-AB8F0C01-F842-4E29-AE5B-CF30CBC4418CQ35788526-E03CA0CB-A1D6-44F9-A91F-7E49EF5282E7Q35809487-5C424B29-01EA-439C-8FA5-D2127A31C2CCQ35830556-A8015673-0348-4AAB-808C-27D1BF1FA16AQ35917533-F45A5E10-0897-4400-81D3-6CE7A18CCF63Q35937990-66DA758B-431E-4BFB-98F4-EF5F0D60B699Q35952718-2914178B-E095-4919-9016-5F28F3821B6DQ35960319-1D0C33C8-68C1-45B3-A498-A64229BE8B2FQ36013430-4B395B4A-D62C-469F-87F9-9541F2ED51EC
P2860
A multicenter randomized controlled trial of nevirapine versus a combination of zidovudine and lamivudine to reduce intrapartum and early postpartum mother-to-child transmission of human immunodeficiency virus type 1.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
A multicenter randomized contr ...... immunodeficiency virus type 1.
@en
A multicenter randomized contr ...... immunodeficiency virus type 1.
@nl
type
label
A multicenter randomized contr ...... immunodeficiency virus type 1.
@en
A multicenter randomized contr ...... immunodeficiency virus type 1.
@nl
prefLabel
A multicenter randomized contr ...... immunodeficiency virus type 1.
@en
A multicenter randomized contr ...... immunodeficiency virus type 1.
@nl
P2093
P50
P356
P1476
A multicenter randomized contr ...... immunodeficiency virus type 1.
@en
P2093
Cheryl Nikodem
David Hall
Jagidesa Moodley
James McIntyre
John L Sullivan
Justus Hofmyer
Lynette Boshoff
Maria Gigliotti
Patrick Robinson
South African Intrapartum Nevirapine Trial (SAINT) Investigators
P304
P356
10.1086/367898
P407
P577
2003-02-24T00:00:00Z